You are here: Industry Insights > Remdesivir

News List

Cipla launches remdesivir under brand name CIPREMI expresspharma
June 22, 2020
The product will be in the form of lyophilised powder for injection 100 mg.
Generic remdesivir may put pricing pressure on Indian pharma, says analyst europeanpharmaceuticalreview
June 19, 2020
According to an expert, Indian pharmaceutical companies will have to price remdesivir cautiously to ward off generic competition in the near future.
Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19 worldpharmanews
June 17, 2020
Gilead Sciences, Inc. announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia.
US FDA warns against co-administration of remdesivir and chloroquine or HCQ expresspharma
June 17, 2020
The drug regulator informs that this may reduce the antiviral activity of remdesivir and lessen the effectiveness of COVID-19 treatment.
Zydus Cadila inks licensing pact with Gilead for remdesivir expresspharma
June 16, 2020
The licence is royalty-free until another pharma product or vaccine is approved for the treatment or prevention of COVID-19 by the USFDA or EMA or the WHO announcing the end of the public health emergency.
Centre clarifies reasons for delay in approvals for remdesivir expresspharma
June 16, 2020
Informs that it is awaiting data on some crucial parameters from companies that have applied for manufacturing and marketing approvals.
Singapore approves Gilead’s remdesivir to treat Covid-19 pharmaceutical-technology
June 15, 2020
Singapore’s Health Sciences Authority (HSA) has awarded conditional approval for Gilead Sciences Singapore’s experimental antiviral drug remdesivir, under the brand name Veklury, to treat adults with Covid-19.
Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir expresspharma
June 15, 2020
Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up and obtain regulatory approval for marketing of this drug in respective countries.
Remdesivir, tocilizumab and CPT included in revised protocols for COVID-19 clinical management expresspharma
June 15, 2020
Hydroxychloroquine can be prescribed in the early stages of COVID-19 infection but not for patients with severe disease, use of azithromycin has been discontinued.
Remdesivir, tocilizumab being considered for ‘restricted use’ on severely ill COVID-19 patients expresspharma
June 12, 2020
Reportedly, some more drugs to be used in combination with hydroxychloroquine may be added to the protocol.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page